SQSTM1 and cancer: Phosphorylated p62 then targets KEAP1 for autophagic degradation, thus activating NRF2, which proceeds to activate its target genes, including p62/SQSTM1 itself, leading to a positive feedback loop whose malfunction is implicated in cancer and neurodegeneration [71,72,73,74,75,76].